Clinical Trials Browser

Phase 2 × OTHER × GSK2141795 × Clear all

NCT01941927 2020-02-12

Trametinib With GSK2141795 in BRAF Wild-type Melanoma

Phase 2 Completed

20 enrolled 16 charts

Melanoma

NCT01958112 2019-05-31

GSK1120212+GSK2141795 for Cervical Cancer

Phase 2 Terminated

14 enrolled 10 charts

Uterine Cervical Neoplasms